Humanin vs Mots C
Evidence tier, human-evidence strength, regulatory status, and hype-vs-data — side by side.
On published evidence, Mots C currently grades higher (F-tier vs F-tier). That reflects evidence maturity, not that it's “better” for any person or goal.
- Stronger human evidence: comparable
- More hype than data: neither stands out
| humanin | mots-c | |
|---|---|---|
| Class | Mitochondrial & longevity peptides | Mitochondrial & longevity peptides |
| Regulatory status | Research-use-only | Research-use-only |
| Candidate sources | 0 | 0 |
| Top study types (candidate) | — | — |
| Translation risk | pending review | pending review |
Humanin vs Mots C: FAQ
Is Humanin better than Mots C?
On published evidence, Mots C currently grades higher (F-tier vs F-tier). That reflects evidence maturity, not that it's “better” for any person or goal. Neither is a recommendation to use anything; this compares the state of the evidence only.
What's the difference between Humanin and Mots C?
Humanin is research-use-only and sits at the “Animal” evidence stage; Mots C is research-use-only and sits at “Animal.”
Which has stronger human evidence, Humanin or Mots C?
Both have comparable human-evidence levels on our scale.
Research reference only. Not medical advice, treatment instructions, or a purchase recommendation. Consult a licensed professional.